Multilevel Intervention for Lung Cancer Screening and Smoking Cessation in African Americans

This study is testing a "Smoking cessation multilevel Intervention" to help African American smokers quit and encourage participation in lung cancer screening. The intervention uses a multi-level approach to support individuals, institutions, and communities. Researchers want to see if this intervention helps people quit smoking (measured by how many days they go without smoking) and how their readiness to quit changes over time. You may be able to join if you are an African American, aged 50-80, have smoked for at least 20 "pack years" (a way to measure how much someone has smoked), are currently smoking, and are eligible for or have already had a low-dose CT (LDCT) scan for lung cancer. The study plans to enroll 250 people, but its current status is unclear.

Study design
This is an interventional study with a planned enrollment of 250 participants. The phase of the study is not specified.
What's involved
Your participation would involve assessments at the beginning of the study, immediately after the intervention, and at a 6-month follow-up.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 6 months after the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07576595

Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans

Recruiting
NAAges 50–80InterventionalPrevention
Louisiana State University Health Sciences Center in New Orleans
~250 participants
Updated 2026-05-11 on ClinicalTrials.gov
What's tested:Smoking cessation multilevel Intervention

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Stage of Change for Smoking Cessation
Measured over Baseline, immediately post-intervention, and 6-month follow-up
+4 more outcomes measured
Lung Cancer Screening
Tobacco Use Disorder
Smoking Cessation
2 sites across 1 states
Louisiana2
  • Tung Sung Tseng, DrPH, MS · PRINCIPAL_INVESTIGATOR · LSUHSC New Orleans

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

African American
20+ pack years of smoking
eligible for or received LDCT screening
current smoker
English speaking

Exclusion

N/A
  • Stage of Change for Smoking CessationBaseline, immediately post-intervention, and 6-month follow-up

    Stage of change in smoking cessation behavior

  • 7-Day Point Prevalence Abstinence RateBaseline, immediately post-intervention, and 6-month follow-up

    Proportion of participants reporting no smoking in the past 7 days

  • 24-Hour Point Prevalence Abstinence RateBaseline, immediately post-intervention, and 6-month follow-up

    Proportion of participants reporting no smoking in the past 24 hours

  • Daily Cigarette ConsumptionBaseline, immediately post-intervention, and 6-month follow-up

    Number of cigarettes smoked per day

  • Nicotine Dependence (Fagerström Test for Nicotine Dependence)Baseline, immediately post-intervention, and 6-month follow-up

    Nicotine dependence measured using the Fagerström Test for Nicotine Dependence (FTND), range 0-10, higher scores indicate greater dependence